<DOC>
	<DOCNO>NCT01617174</DOCNO>
	<brief_summary>The first goal study learn experience pain symptom men treat advanced prostate cancer . The second goal study identify reliable way measure pain use future clinical trial treatment advanced prostate cancer .</brief_summary>
	<brief_title>Observational Longitudinal Study Pain Men With Metastatic Castrate-Resistant Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>The subject must â‰¥ 18 year old day consent . The subject able understand write spoken English . The patient must histologically cytologically confirm prostate adenocarcinoma . The subject must castrationresistant prostate cancer ( CRPC ) . The subject must metastatic disease involve bone , see radiographic imaging ( bone scan , CT scan , PET scan , MRI ) . The subject must castrate state ( e.g. , currently receive androgen deprivation therapy orchiectomy ) . The subject must start line systemic treatment postandrogen deprivation/antiandrogen therapy , follow : chemotherapy ( e.g. , docetaxel , paclitaxel , carboplatin , cabazitaxel , mitoxantrone ) ; abiraterone acetate ; MDV3100 ; ketoconazole ; clinical trial . The subject own regular access telephone ( cellular land line ) . The subject willing able selfreport pain analgesic use via automate telephone system . The subject willing able provide inform consent . The subject small cell predominantly neuroendocrine differentiate prostate tumor .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>prostate</keyword>
	<keyword>pain assessment</keyword>
	<keyword>12-110</keyword>
</DOC>